Compare Stocks: IBAC, QSI, CDXS, and MXCT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDXS Codexis	$1.43 0.0%	$1.78	$0.96 ▼ $2.98	$156.55M	2.52	1.52 million shs	172,131 shs
IBAC IB Acquisition	$10.92 +0.1%	$10.81	$10.19 ▼ $11.45	$54.71M	N/A	799 shs	1,122 shs
MXCT MaxCyte	$1.20 -2.0%	$1.24	$0.64 ▼ $1.87	$123.34M	1.52	1.06 million shs	121,000 shs
QSI Quantum-Si	$0.73 -2.8%	$0.80	$0.69 ▼ $3.10	$159.56M	3.25	4.50 million shs	810,017 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDXS Codexis	0.00%	-3.05%	-4.67%	-40.66%	-41.63%
IBAC IB Acquisition	0.00%	+0.41%	+0.79%	+1.95%	+3.16%
MXCT MaxCyte	-4.31%	-3.94%	+0.83%	+10.91%	-14.08%
QSI Quantum-Si	-1.32%	-1.45%	-5.08%	-22.92%	-34.78%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDXS Codexis	$1.43 0.0%	$1.78	$0.96 ▼ $2.98	$156.55M	2.52	1.52 million shs	172,131 shs
IBAC IB Acquisition	$10.92 +0.1%	$10.81	$10.19 ▼ $11.45	$54.71M	N/A	799 shs	1,122 shs
MXCT MaxCyte	$1.20 -2.0%	$1.24	$0.64 ▼ $1.87	$123.34M	1.52	1.06 million shs	121,000 shs
QSI Quantum-Si	$0.73 -2.8%	$0.80	$0.69 ▼ $3.10	$159.56M	3.25	4.50 million shs	810,017 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDXS Codexis	0.00%	-3.05%	-4.67%	-40.66%	-41.63%
IBAC IB Acquisition	0.00%	+0.41%	+0.79%	+1.95%	+3.16%
MXCT MaxCyte	-4.31%	-3.94%	+0.83%	+10.91%	-14.08%
QSI Quantum-Si	-1.32%	-1.45%	-5.08%	-22.92%	-34.78%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDXS Codexis	2.25	Hold	$6.50	354.70% Upside
IBAC IB Acquisition	1.00	Sell	N/A	N/A
MXCT MaxCyte	2.00	Hold	$5.00	318.41% Upside
QSI Quantum-Si	2.00	Hold	$1.00	37.17% Upside

Current Analyst Ratings Breakdown

Latest IBAC, QSI, CDXS, and MXCT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/8/2026	MXCT MaxCyte	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/2/2026	CDXS Codexis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/27/2026	IBAC IB Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/25/2026	MXCT MaxCyte	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/25/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/24/2026	MXCT MaxCyte	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
8/20/2026	CDXS Codexis	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
8/17/2026	CDXS Codexis	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$9.00 ➝ $8.00
8/14/2026	IBAC IB Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
8/14/2026	QSI Quantum-Si	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/11/2026	MXCT MaxCyte	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDXS Codexis	$70.39M	2.22	N/A	N/A	$0.56 per share	2.55
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
MXCT MaxCyte	$33.03M	3.73	N/A	N/A	$1.61 per share	0.74
QSI Quantum-Si	$2.44M	65.39	N/A	N/A	$1.02 per share	0.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDXS Codexis	-$43.97M	-$0.34	N/A	N/A	N/A	-39.55%	-74.36%	-23.58%	11/5/2026 (Estimated)
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MXCT MaxCyte	-$44.63M	-$0.33	N/A	N/A	N/A	-114.77%	-18.92%	-16.14%	11/11/2026 (Estimated)
QSI Quantum-Si	-$101.34M	-$0.46	N/A	N/A	N/A	-6,138.26%	-47.12%	-43.18%	11/4/2026 (Estimated)

Latest IBAC, QSI, CDXS, and MXCT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	QSI Quantum-Si	-$0.1133	-$0.11	+$0.0033	-$0.11	$0.30 million	$0.34 million
8/12/2026	Q2 2026	MXCT MaxCyte	-$0.09	-$0.08	+$0.01	-$0.08	$6.51 million	$6.50 million
8/11/2026	Q2 2026	CDXS Codexis	-$0.1417	-$0.13	+$0.0117	-$0.13	$13.82 million	$14.92 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDXS Codexis	N/A	N/A	N/A	N/A	N/A
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A
MXCT MaxCyte	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDXS Codexis	1.03	3.06	2.99
IBAC IB Acquisition	N/A	N/A	N/A
MXCT MaxCyte	N/A	12.26	11.47
QSI Quantum-Si	N/A	9.97	9.80

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDXS Codexis	78.54%
IBAC IB Acquisition	N/A
MXCT MaxCyte	68.81%
QSI Quantum-Si	39.90%

Insider Ownership

Company	Insider Ownership
CDXS Codexis	3.50%
IBAC IB Acquisition	N/A
MXCT MaxCyte	4.10%
QSI Quantum-Si	22.04%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDXS Codexis	250	109.51 million	105.67 million	Optionable
IBAC IB Acquisition	N/A	5.01 million	N/A	N/A
MXCT MaxCyte	80	103.21 million	98.98 million	Optionable
QSI Quantum-Si	150	218.88 million	170.64 million	Optionable

IBAC, QSI, CDXS, and MXCT Headlines

Recent News About These Companies

Quantum-Si (NASDAQ:QSI) Shares Down 1.3% - What's Next?

September 10 at 1:39 AM | marketbeat.com

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

September 9 at 8:00 AM | globenewswire.com

Quantum‑Si Earnings Call: Proteus Delay, Runway Extended

August 22, 2026 | theglobeandmail.com

Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

August 18, 2026 | globenewswire.com

FY2026 EPS Estimates for Quantum-Si Lifted by HC Wainwright

August 18, 2026 | marketbeat.com

Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

Quantum-Si Q2 Earnings Call Highlights

August 13, 2026 | marketbeat.com

Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates

August 13, 2026 | zacks.com

Quantum-Si (NASDAQ:QSI) Announces Quarterly Earnings Results

August 13, 2026 | marketbeat.com

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

August 13, 2026 | globenewswire.com

Stock Traders Purchase Large Volume of Call Options on Quantum-Si (NASDAQ:QSI)

August 13, 2026 | marketbeat.com

Quantum-Si Q2 2026 earnings preview

August 12, 2026 | msn.com

Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026

July 27, 2026 | globenewswire.com

Why Quantum-Si incorporated’s (QSI) Stock Is Up 5.02%

July 1, 2026 | aaii.comA

Quantum-Si (NASDAQ:QSI) CEO Jeffrey Alan Hawkins Sells 11,311 Shares

June 25, 2026 | insidertrades.com

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 16, 2026 | businesswire.com

Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™

June 10, 2026 | rutlandherald.comR

Why Quantum-Si incorporated’s (QSI) Stock Is Down 7.81%

June 8, 2026 | aaii.comA

Quantum-Si Announces the Expansion of the Proteus™ Roadshow

June 3, 2026 | finance.yahoo.com

Quantum-Si Announces the Expansion of the Proteus™ Roadshow

June 3, 2026 | businesswire.com

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?

June 1, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBAC, QSI, CDXS, and MXCT Company Descriptions

Codexis NASDAQ:CDXS

$1.43 0.00 (-0.03%)

As of 11:27 AM Eastern

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

IB Acquisition NASDAQ:IBAC

$10.92 +0.01 (+0.09%)

As of 11:23 AM Eastern

IB Acquisition Corp. is a blank check company. It formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. IB Acquisition Corp. is based in Boca Raton, Florida.

MaxCyte NASDAQ:MXCT

$1.20 -0.03 (-2.05%)

As of 11:45 AM Eastern

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Quantum-Si NASDAQ:QSI

$0.73 -0.02 (-2.80%)

As of 11:45 AM Eastern

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IBAC, QSI, CDXS, and MXCT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IBAC, QSI, CDXS, and MXCT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IBAC, QSI, CDXS, and MXCT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBAC, QSI, CDXS, and MXCT Company Descriptions

Codexis NASDAQ:CDXS

IB Acquisition NASDAQ:IBAC

MaxCyte NASDAQ:MXCT

Quantum-Si NASDAQ:QSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IBAC, QSI, CDXS, and MXCT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IBAC, QSI, CDXS, and MXCT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IBAC, QSI, CDXS, and MXCT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBAC, QSI, CDXS, and MXCT Company Descriptions

Codexis NASDAQ:CDXS

IB Acquisition NASDAQ:IBAC

MaxCyte NASDAQ:MXCT

Quantum-Si NASDAQ:QSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools